{"symbol": "APTX", "companyName": "Aptinyx Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "https://www.aptinyx.com", "description": "Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.", "CEO": "Norbert G. Riedel", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}